The independent source for health policy research, polling, and news.
201 - 220 of 760 Results
A dental device called AGGA has been used on about 10,000 patients without FDA approval or proof that it works. In lawsuits, patients report irreparable harm. The AGGA’s inventor and manufacturer have denied all liability in court.
Cue got attention with a Super Bowl ad for a stylish high-tech covid-testing machine to use at home. But the product is expensive, which has limited the San Diego company’s market.
2023 was another busy year in health care. As the covid-19 pandemic waned, policymakers looked anew at long-standing obstacles to obtaining and paying for care in the nation’s health care system. Meanwhile, abortion has continued to be an issue in much of the nation, as states respond to the Supreme Court’s 2022 decision overturning the constitutional right to the procedure. This week, Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and wrap up the year in health. Also this week, Rovner interviews KFF Health News’ Jordan Rau about his joint KFF Health News-New York Times series “Dying Broke.”
Whether a simple operation is performed under the auspices of a hospital or at an independent surgery center can make a huge difference in cost.
If federal officials accept a court’s decision, some patients will get a chance to seek refunds for their nursing home and other expenses.
People in jail who have serious mental illness and cannot stand trial because of their condition are waiting months, or even more than a year, to get into their state psychiatric hospitals.
The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologists’ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.
The Supreme Court’s conservative majority has yet to make clear its stand on Roe v. Wade. But state lawmakers aren’t waiting to consider a variety of extreme measures: bills that would ban abortions in cases of ectopic pregnancies, allow rapists’ families to object to terminating a victim’s pregnancy, or prohibit the procedure in the case of fetal disability. Do these proposals make the less extreme restrictions seem more mainstream?
Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of KFF Health News join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the “Medicaid unwinding” is going, as millions have their eligibility for coverage rechecked.
After a years-long bitter partisan fight over reforming the U.S. Postal Service’s finances and service, congressional leaders say they have a compromise. The bill, which has won endorsements from both Republicans and Democrats on Capitol Hill, would force future Postal Service retirees to use Medicare as their primary source of health coverage.
Legislators in Kansas are pushing bills to expand exemptions for school vaccines, allowing religious exemptions for all vaccine requirements in the state's schools without families having to provide any proof of their beliefs. Similar bills are being introduced around the nation as the anti-vaccine movement gains traction among politicians.
Colorado is among about 15 states that have met federal goals to reduce infant mortality, an important indicator of overall population health. Breaking down the data by race and ethnicity, though, makes clear that major gaps remain.
In the battle against covid, pharmacies became a key place for consumers to seek vaccines and testing. Some states are expanding pharmacists’ work to include directly prescribing drugs for customers who seek some routine, point-of-care tests, such as those for flu or strep throat. But doctor groups oppose the move.
Jan. 22 marks the 49th — and very likely last — anniversary of the Supreme Court’s landmark abortion decision, Roe v. Wade. The court’s conservative supermajority seems poised to overturn later this year the ruling that legalized abortion nationwide. Also this week, the Biden administration turns 1, with much of its domestic and health agenda yet unrealized. Alice Miranda Ollstein of Politico, Shefali Luthra of the 19th, and Kimberly Leonard of Insider join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Marjorie Dannenfelser, president of the Susan B. Anthony List, about what a post-Roe world might look like.
In anticipation of the Supreme Court rolling back abortion rights this year, both Democrats and Republicans are arguing among themselves over how best to proceed to either protect or restrict the procedure. Meanwhile, millions of Americans are at risk of losing their health insurance when the federal government declares an end to the current “public health emergency.” Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Jay Hancock, who wrote the latest KHN-NPR “Bill of the Month” episode about a couple whose insurance company deemed their twins’ stay in intensive care not an emergency.
A conversation about how the lessons from the victory over smallpox could be applied to public health challenges today.
Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
The laws governing Medicare don’t provide coverage for self-administered diagnostic tests, which is precisely what the rapid antigen tests are and why they are an important tool for containing the pandemic.
Public opinion remains bitterly divided on the issue as a Supreme Court decision is imminent that could overturn or dramatically undercut Roe v. Wade.
This new variant has set off alarm bells in the public health community, but much remains to be learned about it.
© 2026 KFF